NUVECTIS PHARMA INC (NVCT) Stock Balance Sheet
NASDAQ:NVCT - Nasdaq - US67080T1088 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 29.86M | 18.53M | 19.13M | 19.99M | 5.74M | |||
| Other Current Assets | 284.00K | 74.00K | 59.00K | 410.00K | 90.00K | |||
| Total Current Assets | 30.15M | 18.61M | 19.18M | 20.41M | 5.83M | |||
| Non-Current Assets | ||||||||
| Other Non-Current Assets | N/A | N/A | N/A | 0.00 | 820.00K | |||
| Total Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 830.00K | |||
| TOTAL ASSETS | 30.15M | 18.61M | 19.18M | 20.41M | 6.66M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 5.90M | 6.40M | 4.21M | 2.83M | 540.00K | |||
| Accounts Payable | 2.99M | 2.50M | 2.77M | 2.91M | 1.06M | |||
| Other Current Liabilities | 300.00K | N/A | N/A | 450.00K | 820.00K | |||
| Total Current Liabilities | 9.19M | 8.89M | 6.98M | 6.19M | 2.42M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 9.19M | 8.89M | 6.98M | 6.19M | 2.42M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -78.58M | -73.25M | -54.24M | -31.99M | -12.90M | |||
| Additional Paid In Capital | 99.53M | 82.96M | 66.45M | 46.20M | 1.89M | |||
| Common Shares | 200.00 | 200.00 | 200.00 | 0.00 | 15.25M | |||
| Other Shareholders' Equity | -200.00 | -200.00 | -200.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 23.63M | 19.50M | 17.42M | 14.64M | 240.00K | |||
| Tangible Book Value per Share | 0.89 | 0.50 | 0.70 | 0.97 | -45.88 | |||
| Total Shareholders' Equity | 20.95M | 9.71M | 12.20M | 14.22M | 4.24M | |||
| TOTAL LIABILITIES AND EQUITY | 30.15M | 18.61M | 19.18M | 20.41M | 6.66M | |||
| Statistics | ||||||||
| Current Ratio | 3.28 | 2.09 | 2.75 | 3.30 | 2.41 | |||
| Return On Assets (ROA) | -66.87% | -102.11% | -116.03% | -93.53% | -193.54% | |||
| Return On Equity (ROE) | -96.22% | -195.61% | -182.44% | -134.25% | -304.01% | |||
All data in USD , ROIC based on taxRate of 0.21